| Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers (NCT00279734) | Bristol-Myers Squibb | 2004-08-01 |
| Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis (NCT00234897) | Abbott | 2004-08-01 |
| A Multi-centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Polyethylene-on-metal Bearing in Primary Total Hip Replacement (NCT00208429) | DePuy International | 2004-07-01 |
| Assessment of the Effectiveness of Low-Level Laser Therapy on the Hands of Patients With Rheumatoid Arthritis (NCT00632710) | Federal University of São Paulo | 2004-07-01 |
| Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients (NCT00506896) | Federal University of São Paulo | 2004-07-01 |
| The Effectiveness of a Nighttime Positioning Hand Splint in Patients With Rheumatoid Arthritis (NCT00502424) | Federal University of São Paulo | 2004-07-01 |
| Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans (NCT00595894) | University of Nebraska | 2004-07-01 |
| A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis. (NCT00154336) | Novartis Pharmaceuticals | 2004-07-01 |
| Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT (NCT00236678) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-07-01 |
| A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies (NCT02097745) | Hoffmann-La Roche | 2004-06-01 |
| A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss (NCT00094562) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-06-01 |
| Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP (NCT00144534) | Chugai Pharmaceutical | 2004-06-01 |
| Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects (NCT00252668) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-06-01 |
| A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) (NCT01078558) | AbbVie (prior sponsor, Abbott) | 2004-05-13 |
| Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis (NCT00321217) | Radboud University Medical Center | 2004-05-01 |
| Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) (NCT00259610) | University of Alabama at Birmingham | 2004-05-01 |
| Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab) (NCT00099554) | Amgen | 2004-05-01 |
| Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg (NCT00195338) | Pfizer | 2004-05-01 |
| Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia (NCT00579059) | Biomet Orthopedics, LLC | 2004-05-01 |
| Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate (NCT00083759) | Biogen | 2004-05-01 |
| Develop Biomarkers for Assessing RA Joint Erosion (NCT00154947) | National Taiwan University Hospital | 2004-05-01 |
| Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis (NCT00291915) | Goupe d'Etudes et de Recherche Clinique En Rhumatologie | 2004-05-01 |
| A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA (NCT00195403) | Pfizer | 2004-05-01 |
| Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP (NCT00144547) | Chugai Pharmaceutical | 2004-04-01 |
| A Clinical Investigation of the Copeland™ Humeral Resurfacing Head (NCT00698750) | Biomet Orthopedics, LLC | 2004-04-01 |
| Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice (NCT01077258) | AbbVie (prior sponsor, Abbott) | 2004-04-01 |
| A Two Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Metal-on-Metal Bearing in Primary Total Hip Replacement (NCT00208364) | DePuy International | 2004-04-01 |
| Cormet Large Diameter Metal on Metal (LDMOM) Total Hip System (G030265) (NCT00867256) | Corin | 2004-03-31 |
| The Effects of a 16-Week Individualized, Intensive Strength Training Program in Patients With Rheumatoid Arthritis (NCT00327275) | University of Arizona | 2004-03-01 |
| Comparison of Rotating vs. Fixed Platform of the COLUMBUS Knee Prosthesis (NCT00822640) | Aesculap AG | 2004-03-01 |
| Comorbidities and Outcomes in Early Rheumatoid Arthritis (NCT03675516) | Momentum Data | 2004-03-01 |
| Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED) (NCT00725621) | Merck Sharp & Dohme LLC | 2004-03-01 |
| A Clinical Investigation of the Vanguard™ Complete Knee System (NCT00698854) | Zimmer Biomet | 2004-03-01 |
| Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children (NCT00484809) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-03-01 |
| INCMNSZ - Rheumatoid Arthritis Cohort (NCT03389711) | National Institute of Medical Sciences and Nutrition, Salvador Zubiran | 2004-02-04 |
| Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA) (NCT00144521) | Chugai Pharmaceutical | 2004-02-01 |
| Rosuvastatin in Rheumatoid Arthritis (RORA) (NCT00679510) | University of Dundee | 2004-02-01 |
| Healthier Living With Arthritis Online Program (NCT00398255) | Stanford University | 2004-02-01 |
| Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94 (NCT00617032) | Targeted Genetics Corporation | 2004-02-01 |
| A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis (NCT00077870) | Genentech, Inc. | 2004-02-01 |
| Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis (NCT00072657) | University of California, Los Angeles | 2004-02-01 |
| The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists (NCT00224562) | Assistance Publique - Hôpitaux de Paris | 2004-02-01 |
| A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis (NCT00647491) | Abbott | 2004-02-01 |
| A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231) (NCT00157872) | Merck Sharp & Dohme LLC | 2004-01-07 |
| Quality of Life Study With Adalimumab in Rheumatoid Arthritis (NCT00234936) | Abbott | 2003-12-01 |
| Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy (NCT00076206) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-12-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate (NCT00619905) | Novartis | 2003-12-01 |
| Cementless Alumina-Alumina Total Hip and Hybrid (NCT00764530) | Encore Medical, L.P. | 2003-11-01 |
| A Single Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery (NCT00872794) | DePuy International | 2003-11-01 |
| An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis (NCT00207714) | Centocor, Inc. | 2003-11-01 |
| OTIS Humira Pregnancy Registry (NCT01086059) | University of California, San Diego | 2003-11-01 |
| Activity, Rheumatoid and Osteoarthritis, and Weight Management (NCT00365404) | HealthPartners Institute | 2003-10-01 |
| Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis (NCT00649922) | Abbott | 2003-10-01 |
| Medical In-Patient Rehabilitation in Rheumatoid Arthritis (NCT00229541) | University of Luebeck | 2003-10-01 |
| Work Interventions to Improve Employment Outcomes for Persons With Rheumatoid Arthritis and Osteoarthritis (NCT00485914) | University of Missouri-Columbia | 2003-10-01 |
| RAHelp.Org: An Online Self Management Program for Adults With Rheumatoid Arthritis (NCT00283855) | University of Missouri-Columbia | 2003-10-01 |
| An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy (NCT00162201) | Bristol-Myers Squibb | 2003-10-01 |
| Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases (NCT00069342) | National Institutes of Health Clinical Center (CC) | 2003-09-22 |
| Post-marketing Observational Study in Subjects With Rheumatoid Arthritis (NCT00234884) | Abbott | 2003-09-01 |
| Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate (NCT00069017) | MedImmune LLC | 2003-09-01 |
| Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis (NCT00221000) | Mallinckrodt | 2003-08-01 |
| Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain (NCT00195364) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-07-01 |
| Health Benefits of an Exercise Program for Adults With Arthritis (NCT00146393) | Centers for Disease Control and Prevention | 2003-07-01 |
| A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery (NCT00208377) | DePuy International | 2003-07-01 |
| Meditation-Based Stress Reduction in Rheumatoid Arthritis (NCT00071292) | National Center for Complementary and Integrative Health (NCCIH) | 2003-07-01 |
| Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate (NCT00235859) | Abbott | 2003-07-01 |
| Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate (NCT00647920) | Abbott | 2003-07-01 |
| Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis (NCT00074438) | Genentech, Inc. | 2003-06-01 |
| Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept (NCT00317538) | Centocor Ortho Biotech Services, L.L.C. | 2003-06-01 |
| Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis (NCT00235833) | Abbott | 2003-06-01 |
| Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis (NCT00213538) | University Hospital, Rouen | 2003-06-01 |
| Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine (NCT00062465) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2003-06-01 |
| Program Evaluation of People With Arthritis Can Exercise (NCT00153309) | Centers for Disease Control and Prevention | 2003-06-01 |
| Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis (NCT00548834) | UCB Pharma | 2003-06-01 |
| A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study (NCT00396747) | Université Catholique de Louvain | 2003-06-01 |
| Study Evaluating Enbrel in Patients With Rheumatoid Arthritis (NCT00245934) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-06-01 |
| A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy (NCT00468546) | Hoffmann-La Roche | 2003-05-01 |
| Leflunomide + Methotrexate in Rheumatoid Arthritis (NCT00563849) | Sanofi | 2003-05-01 |
| Study of Families With Twins or Siblings Discordant for Rheumatic Disorders (NCT00055055) | National Institute of Environmental Health Sciences (NIEHS) | 2003-04-21 |
| Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis (NCT00213564) | University Hospital, Rouen | 2003-04-01 |
| Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice (NCT01078090) | AbbVie (prior sponsor, Abbott) | 2003-04-01 |
| Clinically Important Changes in Rheumatoid Arthritis (NCT00056602) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2003-03-18 |
| Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis (NCT00356473) | University of California, Los Angeles | 2003-03-01 |
| Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis (NCT00234845) | Abbott | 2003-03-01 |
| Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA) (NCT00144508) | Chugai Pharmaceutical | 2003-03-01 |
| Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy (NCT00244556) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-03-01 |
| TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis (NCT00908089) | University of Helsinki | 2003-03-01 |
| Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis (NCT00160693) | UCB Pharma | 2003-03-01 |
| Brigham and Women's Rheumatoid Arthritis Sequential Study (NCT01793103) | Brigham and Women's Hospital | 2003-03-01 |
| Coping Skills Training for Early Rheumatoid Arthritis (NCT00056394) | Duke University | 2003-02-01 |
| A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement (NCT00208390) | DePuy International | 2003-02-01 |
| Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072) (NCT00092742) | Organon and Co | 2003-02-01 |
| Study Evaluating the Efficacy and Safety of Etanercept (NCT00546533) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-01-01 |
| Effect of Exercise on the Disease Activity of Rheumatoid Arthritis (NCT00792675) | University of Nebraska | 2003-01-01 |
| A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis (NCT00048932) | Bristol-Myers Squibb | 2002-12-01 |
| A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate (NCT00048568) | Bristol-Myers Squibb | 2002-12-01 |
| Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017) (NCT00482417) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT) (NCT00764725) | Karolinska Institutet | 2002-12-01 |
| Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. (NCT00048581) | Bristol-Myers Squibb | 2002-12-01 |
| Phase 2 AMG 714 in Rheumatoid Arthritis (NCT00433875) | Amgen | 2002-12-01 |